Tranilast (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tranilast" in English language version.

refsWebsite

Global rank English rank

6nih.gov

4^th place

4doi.org

2^nd place

1gpo.gov

1,360^th place

845^th place

1s3.amazonaws.com

1,540^th place

958^th place

1drugs.com

399^th place

333^rd place

1thepharmaletter.com

low place

1handle.net

102^nd place

76^th place

1springer.com

274^th place

309^th place

1europa.eu

68^th place

117^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Darakhshan S, Pour AB (January 2015). "Tranilast: a review of its therapeutic applications". Pharmacological Research. 91: 15–28. doi:10.1016/j.phrs.2014.10.009. PMID 25447595.
Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, Deng X, Liang G, Zhang H, Jiang W, Zhou R (April 2018). "Tranilast directly targets NLRP3 to treat inflammasome-driven diseases". EMBO Molecular Medicine. 10 (4) e8689. doi:10.15252/emmm.201708689. PMC 5887903. PMID 29531021.
Perálvarez-Marín A, Doñate-Macian P, Gaudet R (November 2013). "What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?". The FEBS Journal. 280 (21): 5471–87. doi:10.1111/febs.12302. PMC 3783526. PMID 23615321.
Holmes DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. (September 2002). "Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial". Circulation. 106 (10): 1243–50. doi:10.1161/01.CIR.0000028335.31300.DA. hdl:1765/9972. PMID 12208800.

drugs.com (Global: 399^th place; English: 333^rd place)

"International brands for Tranilast". Drugs.com. Retrieved 10 March 2018.

europa.eu (Global: 68^th place; English: 117^th place)

ema.europa.eu

"EU/3/10/756 Orphan Designation". European Medicines Agency. 6 August 2010. Retrieved 10 March 2018.

gpo.gov (Global: 1,360^th place; English: 845^th place)

"FDA Proposed Rules" (PDF). Federal Register. 81 (242): 91071–91082. December 16, 2016. Another version of same published at here

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Holmes DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. (September 2002). "Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial". Circulation. 106 (10): 1243–50. doi:10.1161/01.CIR.0000028335.31300.DA. hdl:1765/9972. PMID 12208800.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Darakhshan S, Pour AB (January 2015). "Tranilast: a review of its therapeutic applications". Pharmacological Research. 91: 15–28. doi:10.1016/j.phrs.2014.10.009. PMID 25447595.
Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, Deng X, Liang G, Zhang H, Jiang W, Zhou R (April 2018). "Tranilast directly targets NLRP3 to treat inflammasome-driven diseases". EMBO Molecular Medicine. 10 (4) e8689. doi:10.15252/emmm.201708689. PMC 5887903. PMID 29531021.
Perálvarez-Marín A, Doñate-Macian P, Gaudet R (November 2013). "What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?". The FEBS Journal. 280 (21): 5471–87. doi:10.1111/febs.12302. PMC 3783526. PMID 23615321.
Holmes DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. (September 2002). "Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial". Circulation. 106 (10): 1243–50. doi:10.1161/01.CIR.0000028335.31300.DA. hdl:1765/9972. PMID 12208800.

ncbi.nlm.nih.gov

Huang Y, Jiang H, Chen Y, Wang X, Yang Y, Tao J, Deng X, Liang G, Zhang H, Jiang W, Zhou R (April 2018). "Tranilast directly targets NLRP3 to treat inflammasome-driven diseases". EMBO Molecular Medicine. 10 (4) e8689. doi:10.15252/emmm.201708689. PMC 5887903. PMID 29531021.
Perálvarez-Marín A, Doñate-Macian P, Gaudet R (November 2013). "What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?". The FEBS Journal. 280 (21): 5471–87. doi:10.1111/febs.12302. PMC 3783526. PMID 23615321.

s3.amazonaws.com (Global: 1,540^th place; English: 958^th place)

"FDA Proposed Rules" (PDF). Federal Register. 81 (242): 91071–91082. December 16, 2016. Another version of same published at here

springer.com (Global: 274^th place; English: 309^th place)

adisinsight.springer.com

"Tranilast - Altacor: ALT-401". AdisInsight. Retrieved 10 March 2018.

thepharmaletter.com (Global: low place; English: low place)

"Kissei's existing business flat but R&D pipeline should lead to growth". The Pharma Letter. 8 September 2000.

Tranilast (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

drugs.com (Global: 399th place; English: 333rd place)

europa.eu (Global: 68th place; English: 117th place)